Podcast

Two Doctors on a Similar Path to Help Those with CLL

Author(s):

Kristie L. Kahl

In this week’s episode of CURE Talks Cancer, we spoke with two doctors honored for their efforts to improve the quality of life for those affected by chronic lymphocytic leukemia (CLL).

Two doctors with very different journeys were honored by CURE for their efforts to improve the quality of life for those affected by chronic lymphocytic leukemia (CLL).

At the 2018 CLL Heroes Award ceremony, John C. Byrd, M.D., a researcher and clinical specialist at the Ohio State University Comprehensive Cancer Center-James Cancer Hospital, and Brian Koffman, M.D.C.M., a family doctor who has been diagnosed with CLL and co-founded the CLL Society, were both honored at the event.

This week, both winners tell us more about what they have accomplished in this space, and why being a CLL Hero is important to them.

For more information, visit: curetoday.com.

Related Videos
Image of man with brown hair.
Image of a man wearing a black button-up shirt.
Related Content
Image of red blood cells.
December 18th 2024

Imbruvica-Venetoclax Shows Promise in Managing CLL

Spencer Feldman
A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated CLL, an expert explained.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of a heart monitor.
December 9th 2024

Heart Risk May Occur Less With Some BTK Inhibitors in B-Cell Blood Cancers

Ashley Chan
In patients with certain B-cell blood cancers, heart-related side effects may occur less after receiving second-generation BTK inhibitors.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of blood cells.
December 9th 2024

Calquence Plus Venclexta Combo May Improve Survival in Frontline CLL

Kristie L. Kahl
Calquence plus Venclexta, with or without Gazyva, improved progression-free survival over the standard-of-care chemoimmunotherapy in patients with untreated chronic lymphocytic leukemia.
Illustration of a man with curly hair, wearing round glasses.
November 7th 2024

The Pathway of Cancer is Fraught with Anxiety

Chester Freeman
As a patient with chronic lymphocytic leukemia, I recently gleaned three new insights from my oncologist and phlebotomist.